A patient with advanced HIV/AIDS has been diagnosed with Pneumocystis jirovecii pneumonia (PJP) and is experiencing elevated liver enzymes. What is the most appropriate nursing intervention to address the potential hepatotoxicity associated with the patient's antiretroviral therapy?

C) Monitor liver function tests frequently and report significant changes to the healthcare provider.

A) Discontinue all antiretroviral medications immediately.

B) Administer acetaminophen to manage liver enzyme levels.

C) Monitor liver function tests frequently and report significant changes to the healthcare provider.

D) Increase the dose of antiretroviral medications to overcome resistance.

A patient with advanced HIV/AIDS is diagnosed with Pneumocystis jirovecii pneumonia (PJP) and has a CD4+ T cell count of 120 cells/mm³. The healthcare provider has initiated high-dose trimethoprim-sulfamethoxazole. As the nurse, which is the most important action to ensure successful treatment and prevent further complications?

B) Educate the patient about the importance of medication adherence and assess for potential barriers.

A) Monitor the patient for signs of hepatotoxicity and report any abnormalities immediately.

B) Educate the patient about the importance of medication adherence and assess for potential barriers.

C) Schedule regular blood tests to monitor CD4+ T cell counts and adjust therapy accordingly.

D) Ensure the patient maintains adequate hydration to prevent nephrotoxicity from the medication.

A patient with HIV is being treated for Pneumocystis jirovecii pneumonia (PJP) with high-dose trimethoprim-sulfamethoxazole. After initial improvement, the patient develops a rash, low-grade fever, and gastrointestinal symptoms. What is the most appropriate nursing action in response to these new symptoms?

B) Discontinue the medication immediately and notify the healthcare provider.

A) Continue the current medication and monitor the patient closely.

B) Discontinue the medication immediately and notify the healthcare provider.

C) Administer an antihistamine and reassess the patient's condition after an hour.

D) Increase the supplemental oxygen and document the findings.

A patient with Pneumocystis jirovecii pneumonia (PJP) is experiencing a hypersensitivity reaction to high-dose trimethoprim-sulfamethoxazole, characterized by a persistent rash and gastrointestinal discomfort. Which action should the nurse prioritize to address the patient's current condition?

B) Notify the healthcare provider and prepare to administer an alternative PJP treatment.

A) Discontinue trimethoprim-sulfamethoxazole and administer diphenhydramine.

B) Notify the healthcare provider and prepare to administer an alternative PJP treatment.

C) Increase the patient's fluid intake to flush out the medication.

D) Apply topical corticosteroids to the rash to reduce inflammation.

A patient with HIV is being treated for Pneumocystis jirovecii pneumonia (PJP) but develops leukopenia, elevated liver enzymes, and renal impairment. The healthcare team decides to switch from trimethoprim-sulfamethoxazole to pentamidine. What is the most important nursing consideration when administering pentamidine to this patient?

A) Monitor blood glucose levels closely to detect hypoglycemia or hyperglycemia.

B) Administer pentamidine with food to enhance absorption and reduce gastric irritation.

C) Increase fluid intake to prevent nephrotoxic effects.

D) Ensure the patient is placed in a prone position during the inhalation of pentamidine.

A patient with HIV is being treated for Pneumocystis jirovecii pneumonia (PJP) with trimethoprim-sulfamethoxazole. Recent lab results indicate leukopenia, elevated liver enzymes, and increased serum creatinine. The patient also shows new bilateral ground-glass opacities on a chest X-ray. Considering these findings, which nursing action is most appropriate to prioritize?

C) Collaborate with the healthcare team to initiate pentamidine treatment and monitor for adverse effects.

A) Administer the next dose of trimethoprim-sulfamethoxazole and monitor blood counts closely.

B) Prepare the patient for a bronchoscopy to investigate the cause of ground-glass opacities.

C) Collaborate with the healthcare team to initiate pentamidine treatment and monitor for adverse effects.

D) Educate the patient on the importance of hydration to protect renal function while continuing current therapy.

A patient with HIV and Pneumocystis jirovecii pneumonia (PJP) now presents with worsening respiratory symptoms, renal impairment, and positive blood cultures for Streptococcus pneumoniae. What is the most appropriate nursing intervention to prioritize in this patient's care?

A) Administer the prescribed antibiotic for Streptococcus pneumoniae immediately

B) Initiate increased fluid intake to address the patient's declining renal function

C) Prepare for a bronchoscopy to identify potential secondary infections

D) Educate the patient on the new antiretroviral regimen changes

A patient with HIV is being treated for Pneumocystis jirovecii pneumonia (PJP) and now presents with worsening respiratory symptoms, pleural effusions, and a positive blood culture for Streptococcus pneumoniae. The patient's renal function is declining with rising serum creatinine and mild proteinuria. Which of the following actions should the nurse prioritize to address the patient's current condition?

A) Administer the prescribed antibiotic therapy for Streptococcus pneumoniae promptly.

B) Increase intravenous fluid administration to manage the declining renal function.

C) Initiate the renal-protective agent as recommended by nephrology.

D) Prepare the patient for a bronchoscopy to assess for secondary opportunistic infection.

A patient with Streptococcus pneumoniae infection is experiencing increased respiratory distress, new onset pleuritic chest pain, and worsening renal function. Supplemental oxygen is initiated, and lisinopril is added to the treatment regimen. What is the nurse's priority intervention if the patient's oxygen saturation drops to 85% despite the current oxygen therapy?

A) Increase the oxygen flow rate on the nasal cannula to 5 L/min

B) Call the respiratory therapist to assess the need for mechanical ventilation

C) Prepare the patient for immediate bronchoscopy

D) Reassess the patient's positioning and administer a bronchodilator

A patient with a complex clinical picture presents with increased respiratory distress, new onset of pleuritic chest pain, and worsening renal function. After initiating oxygen therapy, which nursing intervention is most critical to prioritize next?

C) Monitor the patient for signs of acute pulmonary embolism.

A) Administer a prescribed dose of lisinopril to preserve renal function.

B) Initiate a fluid restriction to address mild hyponatremia.

C) Monitor the patient for signs of acute pulmonary embolism.

D) Prepare the patient for a potential bronchoscopy to assess pulmonary status.

aids - Nursing Case Study

Pathophysiology

• Primary mechanism: HIV targets and destroys CD4+ T cells, a type of white blood cell crucial for coordinating the immune response, leading to progressive immunosuppression.

• Secondary mechanism: The virus integrates its genetic material into the host's DNA, allowing it to replicate and persist in the body despite immune defenses and antiretroviral therapy.

• Key complication: As CD4+ T cells decline, the body becomes increasingly vulnerable to opportunistic infections and cancers, which are major causes of morbidity and mortality in AIDS patients.

Patient Profile

Demographics:

42-year-old male, construction worker

History:

• Key past medical history: Diagnosed with HIV 8 years ago, history of recurrent respiratory infections

• Current medications: Antiretroviral therapy (Tenofovir, Emtricitabine, Efavirenz), Bactrim (for prophylaxis)

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent cough and shortness of breath

• Key symptoms: Night sweats, unintentional weight loss, fever, fatigue, swollen lymph nodes

• Vital signs: Temperature 38.5°C (101.3°F), Heart rate 110 bpm, Blood pressure 100/70 mmHg, Respiratory rate 22 breaths per minute, Oxygen saturation 91% on room air

Section 1

New Diagnostic Results:

Following the initial assessment, the healthcare team orders a series of diagnostic tests to better understand the underlying cause of the patient's symptoms. A chest X-ray reveals diffuse interstitial infiltrates, suggestive of Pneumocystis jirovecii pneumonia (PJP), a common opportunistic infection in individuals with advanced HIV/AIDS. Laboratory tests are conducted to confirm this suspicion, including a bronchoalveolar lavage (BAL) which tests positive for PJP. Additionally, a complete blood count (CBC) shows leukopenia with a low white blood cell count of 2,500 cells/μL, and a CD4+ T cell count is alarmingly low at 120 cells/mm³, well below the normal range. This further confirms significant immunosuppression.

The patient's elevated liver enzymes from the comprehensive metabolic panel indicate potential hepatotoxicity, which could be a side effect of prolonged antiretroviral therapy. The viral load is also measured and found to be significantly higher than previous levels, suggesting possible non-adherence to the medication regimen or resistance to the current antiretroviral therapy. These findings necessitate immediate clinical intervention to address both the opportunistic infection and the management of the patient's HIV progression. The healthcare team considers modifying the antiretroviral therapy regimen and initiating treatment with high-dose trimethoprim-sulfamethoxazole for the PJP, while also exploring potential drug interactions and side effects.

This diagnostic stage highlights the complexity of managing HIV/AIDS, particularly when complications like PJP arise. The patient's condition underscores the importance of adherence to treatment and monitoring for early signs of opportunistic infections. These results will guide the next steps in care, focusing on stabilizing the patient's respiratory function, reassessing the current antiretroviral therapy, and addressing potential medication side effects. The healthcare team must also consider the patient's social circumstances and potential barriers to adherence, which are critical for improving long-term outcomes.

Section 2

Change in Patient Status

Following the initiation of high-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (PJP), the patient begins to show signs of respiratory improvement with a decrease in dyspnea and an increase in oxygen saturation levels from 88% on room air to 92% with supplemental oxygen. However, within 48 hours, new symptoms emerge, including a persistent dry cough, low-grade fever, and an unexpected rash characterized by erythematous maculopapular lesions on the torso. The patient also reports gastrointestinal discomfort, including nausea and occasional vomiting.

The healthcare team recognizes these new symptoms as potential side effects of trimethoprim-sulfamethoxazole, possibly indicating a hypersensitivity reaction. Consequently, the team must weigh the benefits of continuing the current treatment for PJP against the risks posed by the adverse reactions. The patient's vital signs reveal a slight increase in heart rate to 105 bpm and a mild fever of 100.8°F, while blood pressure remains stable at 118/76 mmHg. While assessing the rash, the healthcare team notes that it is non-blanching, suggesting the need for close monitoring and possible intervention if the reaction worsens.

In light of the patient's immunocompromised status, the team considers alternative therapies for PJP to reduce the risk of severe hypersensitivity. Discussions also emphasize the need to reassess the antiretroviral therapy regimen due to the elevated viral load, with a focus on potential drug resistance patterns. The team plans to consult with an infectious disease specialist to optimize the management strategy, ensuring the patient receives effective treatment while minimizing adverse effects. This change in status prompts a reevaluation of the patient's overall care plan, highlighting the necessity for a multidisciplinary approach to manage both the immediate complications and the underlying HIV progression.

Section 3

New Diagnostic Results

With the emergence of new symptoms, the healthcare team orders a series of diagnostic tests to further evaluate the patient's condition and guide treatment decisions. A complete blood count reveals leukopenia, with a white blood cell count of 3,500/mm³, suggesting a potential bone marrow suppression effect from the trimethoprim-sulfamethoxazole or an underlying progression of HIV. Liver function tests show mildly elevated transaminases, which could indicate hepatic stress or a drug-induced liver injury. Serum electrolytes remain within normal limits, but a slight elevation in serum creatinine to 1.3 mg/dL raises concerns about renal function, prompting consideration of the nephrotoxic potential of the current therapy.

A chest X-ray is performed to reassess the patient's pulmonary status, and findings indicate a slight improvement in the diffuse interstitial infiltrates, consistent with resolving PJP. However, the presence of new bilateral ground-glass opacities raises the possibility of an additional pulmonary complication, such as an emerging viral or bacterial infection, or an inflammatory response secondary to drug hypersensitivity. Blood cultures and a viral load assessment are also conducted to explore the potential for a concurrent infection and to evaluate the efficacy of the antiretroviral regimen.

The infectious disease specialist recommends switching the patient to an alternative PJP treatment, such as pentamidine, to address the hypersensitivity concerns while maintaining effective anti-pneumocystis coverage. Additionally, a genotypic resistance test is ordered to assess the current antiretroviral therapy's effectiveness and to tailor the regimen more precisely. These diagnostic results and recommendations underscore the complexity of managing an immunocompromised patient with multiple overlapping health challenges, emphasizing the importance of continuous monitoring and collaboration among the healthcare team to adapt to the patient's evolving clinical picture.

Section 4

As the healthcare team closely monitors the patient's progress following the adjustment in treatment for PJP and the ongoing evaluation of renal and hepatic function, new complications begin to emerge. Despite the switch to pentamidine, the patient's respiratory status shows minimal improvement. A repeat chest X-ray reveals a progression of the ground-glass opacities, now accompanied by small pleural effusions. These findings raise the suspicion of a secondary opportunistic infection or a possible drug-induced pulmonary toxicity, necessitating further exploration.

Simultaneously, the patient's renal function continues to decline, with serum creatinine rising to 1.6 mg/dL, and a newly detected mild proteinuria is suggestive of early nephropathy. This development prompts the nephrology team to recommend reducing the dosage of potentially nephrotoxic medications and increasing hydration to mitigate further renal impairment. The interdisciplinary team also considers the introduction of a renal-protective agent, such as an ACE inhibitor, to preserve kidney function.

Meanwhile, blood cultures return positive for a bacterial pathogen, Streptococcus pneumoniae, which could account for the worsening pulmonary symptoms and requires immediate antibiotic therapy. The patient's antiretroviral regimen is adjusted based on the genotypic resistance test results, indicating a need to switch from efavirenz to dolutegravir to enhance viral suppression. These compounding issues highlight the delicate balance of managing this patient's multifaceted medical needs, underscoring the necessity for vigilant assessment and prompt intervention to prevent further deterioration and optimize outcomes.

Section 5

As the healthcare team continues to address the patient's complex clinical picture, a change in patient status becomes evident. The patient exhibits increased respiratory distress, characterized by a respiratory rate of 28 breaths per minute, use of accessory muscles, and oxygen saturation dropping to 88% on room air. This prompts the immediate initiation of supplemental oxygen therapy via nasal cannula at 3 L/min, which helps improve oxygen saturation to 92%. The patient also reports new onset of pleuritic chest pain, particularly on deep inspiration, which raises further concern for an evolving pleural process or worsening infection.

Concurrent with these respiratory changes, the patient's laboratory findings reveal a further elevation in serum creatinine to 1.8 mg/dL and an increase in proteinuria to 500 mg/day, indicating a progression of renal impairment. The nephrology team suggests the addition of lisinopril, an ACE inhibitor, to the treatment regimen to help preserve renal function. Additionally, serum electrolytes show a mild hyponatremia with sodium levels at 132 mEq/L, necessitating close monitoring and potential fluid management adjustments.

Despite the adjustments in treatment, the patient's condition continues to challenge the healthcare team. The introduction of antibiotics for the Streptococcus pneumoniae infection shows initial promise, with some reduction in fever and stabilization of vital signs, yet it is clear that close monitoring and further diagnostic evaluations are critical. The team discusses the potential need for a bronchoscopy to obtain a more definitive diagnosis of the pulmonary complications and considers the possible role of therapeutic thoracentesis if pleural effusions continue to expand. These developments require the team to reassess the patient's priorities and adjust the care plan to prevent further clinical decline, integrating insights from infectious disease, pulmonology, and nephrology specialties.